Skip to main content
. Author manuscript; available in PMC: 2018 Jun 20.
Published in final edited form as: Am J Perinatol. 2016 Apr 8;33(9):894–902. doi: 10.1055/s-0036-1581080

Table 2.

Indications and laboratory findings among infants tested for postnatal CMV

CMV positive
N = 27/tests = 48
CMV negative
N = 118/tests = 197
p-Value
Age at testing, median days (IQR) 58 (51–74) 47 (33–62) < 0.001
Times tested per patient, N (%)
 1 15 (55.5) 77 (65.3) 0.59
 2 6 (22.2) 15 (12.7)
 ≥ 3 6 (22.2) 26 (22.0)
Specimen tested, N (%)
 Urine 43 (89.6) 184 (93.4) 0.20
 Cerebrospinal fluid 1 (2.1) 2 (1.0)
 Tracheal aspirate 2 (4.2) 1 (0.5)
 Other 2 (4.2) 10 (5.1)
Indication for testing, N (%)
 Small for gestational age 0 9 (7.6) 0.14
 Thrombocytopenia 18 (66.6) 37 (31.4) < 0.001
 Cholestasis 8 (29.6) 55 (46.6) 0.11
 Part of late-onset sepsis evaluation 13 (48.2) 44 (37.3) 0.23
 New cranial imaging abnormality 1 (3.7) 13 (11) 0.25
 Other indicationsa 3 (11.1) 11 (9.3) 0.78
Incidence of abnormal laboratory values within ± 7 d of CMV test, N (%)b
 Platelet < 100,000 14 (51.9) 27 (28.1) 0.02
 Leukocyte count < 5,000 2 (7.4) 10 (10.5) 1.0
 Absolute neutrophil count < 1,000 11 (40.7) 15 (15.8) 0.005
 Direct bilirubin > 1.0 7 (30.4) 56 (67.5) 0.001
 Aspartate transaminase > 150 8 (33.3) 20 (23.5) 0.33
 Alanine transaminase > 150 3 (12.5) 5 (5.9) 0.37

Abbreviations: CMV, cytomegalovirus; IQR, interquartile range.

a

Other indications among CMV-positive infants: rhinitis, hepatosplenomegaly, sibling tested for CMV. Among CMV-negative infants: retinal scarring, failed hearing screen, recurrent indirect bilirubinemia, rhinitis, diagnostic bronchial lavage sampling, liver calcifications, bloody stool, viral panel performed in response to breastmilk administration error, sibling tested for CMV.

b

Complete blood count was sent for 143 infants (27 CMV positive and 115 CMV negative), direct bilirubin in 106 infants (23 CMV positive and 83 CMV negative), liver transaminases in 109 infants (24 CMV positive and 85 CMV negative).